HEALTHY ADULT PARTICIPANTS

This early-stage study tests a new drug called BGB-45035 for safety and how the body processes it. First, healthy volunteers receive single or multiple doses. Then, people with autoimmune skin diseases like atopic dermatitis (eczema) or prurigo nodularis receive the drug to check…

This study is testing a new nasal spray called RIG-101 to see if it can help prevent asthma symptoms from getting worse when people catch a common cold. The trial has two parts: first checking the spray's safety in healthy people, then testing if it reduces breathing problems in …

This study explores how a safe, non-invasive brain stimulation technique called transcranial random noise stimulation affects language performance. Healthy adults will perform language tasks while receiving either real or fake stimulation, without knowing which. The goal is to be…

This study looks at how runners' emotions and coping strategies change during an 80-kilometer ultra-endurance race and how these factors affect their performance and fatigue. Researchers will track 80 healthy adult participants before, during, and after the race using surveys and…

This early-stage study tests the safety of a new drug called ADX-626 in 44 healthy adults aged 18 to 45. Researchers will monitor side effects and measure how the drug moves through the body. No treatment benefit is expected; the goal is to gather essential safety data before tes…

This early-stage study tests CPV-104, a new medicine for C3 glomerulopathy (C3G), a rare kidney disease. Healthy volunteers get one dose, and C3G patients get four weekly doses to check safety and how the body handles the drug. The main goal is safety, not effectiveness, and a sa…

This study looks at whether slow, steady breathing at 6 breaths per minute can lower stress more than breathing at a normal pace or just sitting still. Researchers will compare three groups of healthy adults to see if the specific rhythm offers unique benefits. Participants will …

This study tests a new radioactive tracer called [18F]GATT-44 to see how well it can image GABA transporters in the brain using PET scans. It involves 32 healthy adults aged 18 to 60. The goal is to measure how the tracer moves in the body, its safety, and how reproducible the re…

This study is testing a robot called Regen that helps physical therapists guide patients during walking therapy. Researchers want to see if the robot is safe, easy to use, and can copy a therapist's movements. Ten healthy adults aged 18-50 will walk on a treadmill while using the…

This study looks at whether a new drug called BV100 affects how the body processes another drug, polymyxin B. It involves 16 healthy adults who will receive both drugs in a set order. The goal is to measure drug levels and check for side effects, not to treat any disease.

This early-stage trial in 60 healthy Chinese adults checks how the body processes a new drug (SIM0270) when taken with other medicines like itraconazole, rifampin, or midazolam. The goal is to measure drug levels in the blood, not to treat any disease. Participants must be health…

This study looks at how runners' minds cope during a very long 120-kilometer race. Researchers want to understand how defense mechanisms and emotional control affect feelings and tiredness. About 80 healthy adults who are already signed up for the race will take part. The goal is…

This study looks at how eating kimchi, a fermented cabbage dish, affects the gut health of healthy adults. Researchers want to see if kimchi increases good bacteria in the gut and improves digestion. Participants will eat either kimchi or plain cabbage every day for 3 weeks and p…

This study is testing a Turkish version of a questionnaire called PRoTECT, which looks at what parents and future parents know and think about toxic chemicals in the environment and how they might affect children's development. About 204 healthy adults will take part. The goal is…

This early-stage study is testing a new drug, ALXN2230, in 48 healthy adults to see if it is safe and how the body processes it. Participants receive a single injection of either the drug or a placebo. The study tracks side effects, drug levels in the blood, and immune responses.